Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries.

Vergne L, Malonga-Mouellet G, Mistoul I, Mavoungou R, Mansaray H, Peeters M, Delaporte E.

J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):165-8.

PMID:
11832686
2.
3.

Relationships among various nucleoside resistance-conferring mutations in the reverse transcriptase of HIV-1.

Turner D, Brenner B, Wainberg MA.

J Antimicrob Chemother. 2004 Jan;53(1):53-7. Epub 2003 Nov 25. Review.

PMID:
14645322
4.
5.

Genotypic resistance tests for the management of the HIV-infected patient with non-B viral isolates.

Visco-Comandini U, Balotta C.

Scand J Infect Dis Suppl. 2003;106:75-8. Review.

PMID:
15000590
6.

Drug resistance in non-subtype B HIV-1.

Kantor R, Katzenstein D.

J Clin Virol. 2004 Mar;29(3):152-9. Review.

PMID:
14962783
7.

A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.

Pinheiro Edos S, Antunes OA, Fortunak JM.

Antiviral Res. 2008 Sep;79(3):143-65. doi: 10.1016/j.antiviral.2008.05.001. Epub 2008 Jun 2. Review.

PMID:
18571246
9.

Sequencing of antiretroviral therapy in children in low- and middle-income countries.

Sohn AH, Nuttall JJ, Zhang F.

Curr Opin HIV AIDS. 2010 Jan;5(1):54-60. doi: 10.1097/COH.0b013e3283339bd8. Review.

PMID:
20046148
11.

Rational approaches to resistance: nucleoside analogues.

Mayers D.

AIDS. 1996 Nov;10 Suppl 1:S9-13. Review.

PMID:
8970670
12.

Current and future management of treatment failure in low- and middle-income countries.

Boyd MA.

Curr Opin HIV AIDS. 2010 Jan;5(1):83-9. doi: 10.1097/COH.0b013e328333b8c0. Review.

PMID:
20046152
13.

A fossil record of zidovudine resistance in transmitted isolates of HIV-1.

Kuritzkes DR.

Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13485-7. Review. No abstract available.

14.

The development of resistance of HIV-1 to zalcitabine.

Craig C, Moyle G.

AIDS. 1997 Mar;11(3):271-9. Review. No abstract available.

PMID:
9147417
15.

Reverse transcription of the HIV-1 pandemic.

Basavapathruni A, Anderson KS.

FASEB J. 2007 Dec;21(14):3795-808. Epub 2007 Jul 17. Review.

PMID:
17639073
16.

Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world.

Frentz D, Boucher CA, van de Vijver DA.

AIDS Rev. 2012 Jan-Mar;14(1):17-27. Review.

PMID:
22297501
17.

Antiretroviral drug resistance--implications for HIV/AIDS reduction in sub-Saharan Africa and other developing countries.

Obiako OR, Murktar HM, Ogoina D.

Niger J Med. 2010 Jul-Sep;19(3):302-10. Review.

PMID:
20845636
18.

Improving first-line antiretroviral therapy in resource-limited settings.

Ford N, Calmy A.

Curr Opin HIV AIDS. 2010 Jan;5(1):38-47. doi: 10.1097/COH.0b013e3283339b41. Review.

PMID:
20046146
19.
20.

HIV sequence databases.

Kuiken C, Korber B, Shafer RW.

AIDS Rev. 2003 Jan-Mar;5(1):52-61. Review.

Supplemental Content

Support Center